As we are merging with the global service provider PharmaLex, our name has been changed to PharmaLex Finland. Being part of PharmaLex Group expands our service portfolio, allowing us to serve you even better and more comprehensively. You now have access to a global network of specialists understanding all regulatory requirements worldwide through the same experts and contact persons as before.
PharmaLex Sweden, PharmaLex Norway, PharmaLex Denmark and PharmaLex Finland will join forces and become a Nordic region powerhouse serving pharma, medtech and biotech companies locally and globally.
From this regional hub you get comprehensive services throughout the Nordic region handling marketing authorisations, registrations and launches in all the Nordic countries. We are also committed to building bridges for local companies to global markets.
PharmaLex is a leading provider of specialised services for the pharma, biotech and medical device industries. We guide you from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-enabled solutions to support you through the entire product lifecycle. We deliver exceptional results — going above and beyond the standard to deliver tailor-made solutions worldwide.
The PharmaLex Group has over 3000 employees with 60+ offices in 32 countries and more than 1,600 satisfies clients worldwide.